Monocyte Regulation in Homeostasis and Malignancy
Amy Robinson1, Claudia Z Han2, Christopher K Glass2
1Medical Research Council (MRC) Centre for Reproductive Health, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Trends in Immunology
|January 15, 2021
Summary
Monocytes, circulating immune cells, are key to detecting disease and differentiating into other immune cells. Cancer can alter monocyte numbers and functions, potentially aiding cancer spread and offering new therapeutic targets.
Area of Science:
- Immunology
- Cell Biology
- Cancer Biology
Background:
- Monocytes are crucial precursors for macrophages and dendritic cells.
- They also function as circulating sensors responding to environmental cues and disease states.
- Recent technological advances have elucidated monocyte production pathways in the bone marrow.
Purpose of the Study:
- To explore the dynamic roles of monocytes beyond their progenitor functions.
- To investigate how monocytes respond to signals in different tissue microenvironments.
- To understand the impact of cancer on systemic monocyte biology.
Main Methods:
- Identification of lineage-determining transcription factors (LDTFs) in monocyte development.
- Analysis of monocyte recruitment to tissues via chemoattractants.
- Assessment of niche-specific signaling in monocyte differentiation.
- Examination of cancer-induced alterations in monocyte subset abundance and transcriptional profiles.
Main Results:
- Monocytes differentiate into macrophages and monocyte-derived dendritic cells (MoDCs).
- Circulating monocytes are influenced by systemic conditions like cancer.
- Cancer alters monocyte abundance and gene expression, potentially promoting metastasis.
Conclusions:
- Monocyte biology in circulation is complex and influenced by disease.
- Cancer-associated changes in monocytes present potential therapeutic avenues.
- Further research into monocyte responses to cancer is warranted.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Differentiation of Common Myeloid Progenitor Cells
3.6K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K
Disorders of Leukocytes
1.6K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.6K
The Tumor Microenvironment
7.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
Receptor Downregulation in MVBs
2.5K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.5K
Mesenchymal Stem Cells
5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K


